ClearPoint Neuro, Inc.
NASDAQ:CLPT
12.89 (USD) • At close November 1, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue
| 23.955 | 20.551 | 16.299 | 12.829 | 11.217 | 7.353 | 7.38 | 5.749 | 4.594 | 3.604 | 3.931 | 5.058 | 3.818 | 2.669 |
| Cost of Revenue
| 10.341 | 7.02 | 5.008 | 3.709 | 3.833 | 2.433 | 2.899 | 2.643 | 1.988 | 1.927 | 1.421 | 0.556 | 0.656 | 0.016 |
| Gross Profit
| 13.614 | 13.531 | 11.291 | 9.12 | 7.384 | 4.92 | 4.481 | 3.107 | 2.607 | 1.677 | 2.509 | 4.503 | 3.162 | 2.653 |
| Gross Profit Ratio
| 0.568 | 0.658 | 0.693 | 0.711 | 0.658 | 0.669 | 0.607 | 0.54 | 0.567 | 0.465 | 0.638 | 0.89 | 0.828 | 0.994 |
| Reseach & Development Expenses
| 11.709 | 10.894 | 8.985 | 4.686 | 2.922 | 2.31 | 2.814 | 2.628 | 1.957 | 3.297 | 2.923 | 1.602 | 4.251 | 5.681 |
| General & Administrative Expenses
| 11.756 | 9.611 | 8.761 | 5.27 | 4.3 | 4.326 | 4.046 | 4.19 | 0 | 0 | 0 | 0 | 0 | 0 |
| Selling & Marketing Expenses
| 12.595 | 9.358 | 6.919 | 5.384 | 4.756 | 3.532 | 3.956 | 3.777 | 0 | 0 | 0 | 0 | 0 | 0 |
| SG&A
| 24.351 | 18.969 | 15.68 | 10.654 | 9.055 | 7.858 | 8.003 | 7.967 | 8.371 | 8.039 | 7.061 | 6.03 | 4.832 | 4.699 |
| Other Expenses
| -0.029 | -0.022 | -0.063 | 0.882 | 0.009 | 0 | 0.017 | 0.216 | 0.231 | 1.803 | 0.864 | 0.003 | 0.105 | 0.414 |
| Operating Expenses
| 36.06 | 29.863 | 24.665 | 15.34 | 11.978 | 10.168 | 10.817 | 10.595 | 10.328 | 11.337 | 9.984 | 7.632 | 9.083 | 10.38 |
| Operating Income
| -22.446 | -16.332 | -13.374 | -6.22 | -4.594 | -5.248 | -6.336 | -7.489 | -8.974 | -5.321 | -7.475 | -3.129 | -5.922 | -9.515 |
| Operating Income Ratio
| -0.937 | -0.795 | -0.821 | -0.485 | -0.41 | -0.714 | -0.859 | -1.303 | -1.953 | -1.476 | -1.902 | -0.619 | -1.551 | -3.565 |
| Total Other Income Expenses Net
| 0.357 | -0.103 | -1.036 | -0.562 | -0.946 | 0.065 | 0.041 | 0.47 | 0.518 | 6.142 | 0.864 | 0.003 | 0.105 | -0.147 |
| Income Before Tax
| -22.089 | -16.435 | -14.41 | -6.782 | -5.54 | -6.163 | -7.167 | -8.07 | -8.449 | -4.525 | -7.086 | -5.707 | -8.311 | -9.454 |
| Income Before Tax Ratio
| -0.922 | -0.8 | -0.884 | -0.529 | -0.494 | -0.838 | -0.971 | -1.404 | -1.839 | -1.255 | -1.803 | -1.128 | -2.177 | -3.542 |
| Income Tax Expense
| 1.289 | 0.103 | 0.91 | 2.326 | 0.964 | 0.065 | 0.89 | 1.276 | 1.493 | 2.433 | 0.913 | 2.166 | 2.498 | 1.59 |
| Net Income
| -22.089 | -16.538 | -15.32 | -9.108 | -6.504 | -6.163 | -7.167 | -8.07 | -8.449 | -4.525 | -7.086 | -5.707 | -8.311 | -9.454 |
| Net Income Ratio
| -0.922 | -0.805 | -0.94 | -0.71 | -0.58 | -0.838 | -0.971 | -1.404 | -1.839 | -1.255 | -1.803 | -1.128 | -2.177 | -3.542 |
| EPS
| -0.9 | -0.68 | -0.74 | -0.57 | -0.49 | -0.56 | -0.93 | -2.93 | -4.48 | -3.06 | -4.95 | -5.65 | -20.73 | -23.76 |
| EPS Diluted
| -0.9 | -0.68 | -0.74 | -0.57 | -0.49 | -0.56 | -0.93 | -2.93 | -4.48 | -3.06 | -4.95 | -5.65 | -20.73 | -23.76 |
| EBITDA
| -20.989 | -15.577 | -12.745 | -4.785 | -4.334 | -5.138 | -6.203 | -7.108 | -7.262 | -7.856 | -6.611 | -3.126 | -5.563 | -7.45 |
| EBITDA Ratio
| -0.876 | -0.758 | -0.782 | -0.373 | -0.386 | -0.699 | -0.841 | -1.236 | -1.581 | -2.18 | -1.682 | -0.618 | -1.457 | -2.791 |